Clinical Trial Service Unit At Oxford University

DENVER, November 20, 2010 - Around a quarter of all heart attacks, strokes, and operations to open blocked arteries could be avoided in people with chronic kidney disease by using the combination of ezetimibe and simvastatin to lower blood cholesterol levels.